Wize acquires Bitcoin Mining Company – Global

The Israeli company Wize Pharma, which is traded on Wall Street (NYSE: WIZP) and formerly also in Tel Aviv, reports meeting the preconditions for the acquisition of the Australian company Cosmos Capital, which mines digital currencies, including bitcoin. Of Wise with the merger of the operations to a value of about $ 75 million, compared to a value of about $ 20 million in which Wise is currently traded, which until recently was traded at a value of $ 11 million.

The final precondition for the deal was completed with the support of 94.5% of Cosmos’ shareholders in the takeover bid, while the required continuum was 90% response. Cosmos specializes primarily in bitcoin mining and also provides digital infrastructure.

Wize also updated that Cosmos has completed the issuance of unsecured convertible bonds for a period of 6 months and in the amount of $ 21 million, bearing an annual interest rate of 8%. The bonds will be convertible into Cosmos shares at a share price of $ 18.16 Of $ 185 million. If the merger between the two companies is completed before the end of May this year, Cosmos will work to convert the bonds to Wise under the same conditions, but the bonds will be converted into Wise shares at a conversion price of $ 0.339 per share and converted at the earlier of the two dates: 6 months List of Wise shares on NASDAQ.

Prior to the merger, Wise will split its existing biomedical activity, developing a drug to treat inflammatory dry eye (LO2A). Wise chose to make the move after showing good results in early November in Phase II of the clinical trial to treat Shiugren’s syndrome, a dry eye side effect.

The major shareholders in Wise are Yair Goldfinger and Noam Danenberg. Wise entered an investment in the company about a year ago

Bonus Biogroup
+ 1.13%

Bonus Biogroup
134
+1.13%

Base:132.5

opening:133.6

High:139

low:133

change:5,640,949

Page Quote News Graphs Company Profile Recommendations


More articles on the subject:




The Israeli that has been rising recently after launching a number of private placements. In early 2020, Wise acquired a 12% stake in Bonus for about $ 60 million.